333 related articles for article (PubMed ID: 24667590)
41. Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis.
Sheikh IA; Bianchi-Smak J; Laubitz D; Schiro G; Midura-Kiela MT; Besselsen DG; Vedantam G; Jarmakiewicz S; Filip R; Ghishan FK; Gao N; Kiela PR
Gut Microbes; 2024; 16(1):2333483. PubMed ID: 38532703
[TBL] [Abstract][Full Text] [Related]
42. Fecal microbiota transplantation: techniques, applications, and issues.
Borody TJ; Campbell J
Gastroenterol Clin North Am; 2012 Dec; 41(4):781-803. PubMed ID: 23101687
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic potential of fecal microbiota transplantation.
Smits LP; Bouter KE; de Vos WM; Borody TJ; Nieuwdorp M
Gastroenterology; 2013 Nov; 145(5):946-53. PubMed ID: 24018052
[TBL] [Abstract][Full Text] [Related]
44. [Fecal microbiota transfer (FMT) in a patient with refractory irritable bowel syndrome].
Zoller V; Laguna AL; Prazeres Da Costa O; Buch T; Göke B; Storr M
Dtsch Med Wochenschr; 2015 Aug; 140(16):1232-6. PubMed ID: 26261935
[TBL] [Abstract][Full Text] [Related]
45. Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease.
Strömbeck A; Lasson A; Strid H; Sundin J; Stotzer PO; Simrén M; Magnusson MK; Öhman L
BMC Gastroenterol; 2020 May; 20(1):130. PubMed ID: 32366222
[TBL] [Abstract][Full Text] [Related]
46. Enteral nutrition and microflora in pediatric Crohn's disease.
Lionetti P; Callegari ML; Ferrari S; Cavicchi MC; Pozzi E; de Martino M; Morelli L
JPEN J Parenter Enteral Nutr; 2005; 29(4 Suppl):S173-5; discussion S175-8, S184-8. PubMed ID: 15980280
[TBL] [Abstract][Full Text] [Related]
47. Fecal microbiota transplantation broadening its application beyond intestinal disorders.
Xu MQ; Cao HL; Wang WQ; Wang S; Cao XC; Yan F; Wang BM
World J Gastroenterol; 2015 Jan; 21(1):102-11. PubMed ID: 25574083
[TBL] [Abstract][Full Text] [Related]
48. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
[TBL] [Abstract][Full Text] [Related]
49. Fecal microbiota transplantation for Crohn's disease: a systematic review and meta-analysis.
Cheng F; Huang Z; Wei W; Li Z
Tech Coloproctol; 2021 May; 25(5):495-504. PubMed ID: 33759066
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection.
Dutta SK; Girotra M; Garg S; Dutta A; von Rosenvinge EC; Maddox C; Song Y; Bartlett JG; Vinayek R; Fricke WF
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1572-6. PubMed ID: 24440222
[TBL] [Abstract][Full Text] [Related]
51. [Faecal microbiota transplantation: indications in perspective].
van Beurden YH; Terveer EM; Keller JJ; Kuijper EJ; Mulder CJJ; Vandenbroucke-Grauls CMJE
Ned Tijdschr Geneeskd; 2017; 161():D1623. PubMed ID: 29076444
[TBL] [Abstract][Full Text] [Related]
52. Exploring & exploiting our 'other self' - does the microbiota hold the key to the future therapy in Crohn's?
Haag LM; Siegmund B
Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):399-409. PubMed ID: 24913380
[TBL] [Abstract][Full Text] [Related]
53. Fecal transplantation: any real hope for inflammatory bowel disease?
Moayyedi P
Curr Opin Gastroenterol; 2016 Jul; 32(4):282-6. PubMed ID: 27152872
[TBL] [Abstract][Full Text] [Related]
54. Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease.
Tronstad RR; Kummen M; Holm K; von Volkmann HL; Anmarkrud JA; Høivik ML; Moum B; Gilja OH; Hausken T; Baines J; Karlsen TH; Fiskerstrand T; Hov JR
Inflamm Bowel Dis; 2017 Oct; 23(10):1752-1761. PubMed ID: 28902124
[TBL] [Abstract][Full Text] [Related]
55. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
[TBL] [Abstract][Full Text] [Related]
56. Curbing our enthusiasm for fecal transplantation in ulcerative colitis.
Rubin DT
Am J Gastroenterol; 2013 Oct; 108(10):1631-3. PubMed ID: 24091506
[TBL] [Abstract][Full Text] [Related]
57. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.
Scanlan PD; Shanahan F; O'Mahony C; Marchesi JR
J Clin Microbiol; 2006 Nov; 44(11):3980-8. PubMed ID: 16988018
[TBL] [Abstract][Full Text] [Related]
58. Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights.
Foligné B; Plé C; Titécat M; Dendooven A; Pagny A; Daniel C; Singer E; Pottier M; Bertin B; Neut C; Deplanque D; Dubuquoy L; Desreumaux P; Capron M; Standaert A
Cells; 2019 Jun; 8(6):. PubMed ID: 31212833
[TBL] [Abstract][Full Text] [Related]
59. Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease.
Wang AY; Popov J; Pai N
World J Gastroenterol; 2016 Dec; 22(47):10304-10315. PubMed ID: 28058011
[TBL] [Abstract][Full Text] [Related]
60. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
